Literature DB >> 20509104

Antihyperlipidemic effect of protodioscin, an active ingredient isolated from the rhizomes of Dioscorea nipponica.

Tiejie Wang1, Roy C Y Choi, Jun Li, Jun Li, Cathy W C Bi, Linquan Zang, Zhongbo Liu, Tina T X Dong, Kaishun Bi, Karl W K Tsim.   

Abstract

Developing drugs against metabolic-related disorders, including obesity and hyperlipidemia, is of importance for human health. Here, a bioactive phytochemical, protodioscin, isolated from the rhizomes of Dioscorea nipponica (Rhizoma Dioscoreae Nipponicae), was identified for its anti-hyperlipidemic effect. In hyperlipidemic rats, the post-administration of protodioscin significantly reduced the time of blood coagulation. In addition, the blood levels of triglyceride, cholesterol, low-density and high-density lipoproteins were also changed accordingly. Taken together, this was the first report of an antihyperlipidemic effect of protodioscin. Its great availability in various vegetables and medicinal plants will be useful in developing health food supplement(s) and/or drug(s) against hyperlipidemia. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20509104     DOI: 10.1055/s-0030-1249960

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  9 in total

1.  Preparation of progenin III from total steroidal saponins of Dioscorea nipponica Makino using a crude enzyme from Aspergillus oryzae strain.

Authors:  Tingqiang Liu; Hongshan Yu; Chunying Liu; Yongming Bao; Xiangchun Hu; Yuanhao Wang; Bing Liu; Yaoyao Fu; Sihui Tang; Fengxie Jin
Journal:  J Ind Microbiol Biotechnol       Date:  2013-03-08       Impact factor: 3.346

2.  Aqueous extract of dioscorea opposita thunb. normalizes the hypertension in 2K1C hypertensive rats.

Authors:  Nurmuhammat Amat; Raziya Amat; Sajida Abdureyim; Parida Hoxur; Zulpiya Osman; Dolkun Mamut; Anake Kijjoa
Journal:  BMC Complement Altern Med       Date:  2014-01-21       Impact factor: 3.659

3.  Protodioscin, Isolated from the Rhizome of Dioscorea tokoro Collected in Northern Japan is the Major Antiproliferative Compound to HL-60 
Leukemic Cells.

Authors:  Manami Oyama; Tetsuo Tokiwano; Satoru Kawaii; Yasunori Yoshida; Kouichi Mizuno; Keimei Oh; Yuko Yoshizawa
Journal:  Curr Bioact Compd       Date:  2017-06

4.  Simultaneous Determination of 5 Flavonoids and 7 Saponins for Quality Control of Traditional Chinese Medicine Preparation Xinnaoshutong Capsule Using HPLC-VWD-ELSD.

Authors:  Jin Li; Yang Bai; Peng Zhang; Jun He; Jun Cao; Mingrui An; Li-Min Hu; Xiu-Mei Gao; Yan-Xu Chang
Journal:  J Anal Methods Chem       Date:  2017-01-16       Impact factor: 2.193

Review 5.  Structural characteristics, bioavailability and cardioprotective potential of saponins.

Authors:  Deepika Singh; Prabir Kumar Chaudhuri
Journal:  Integr Med Res       Date:  2018-02-03

6.  Antiobesity Activities of Methanolic Extracts of Amaranthus dubius, Cucurbita pepo, and Vigna unguiculata in Progesterone-Induced Obese Mice.

Authors:  Kathryn Wanjiku Nderitu; Njagi Shadrack Mwenda; Ndegwa John Macharia; Stephen Super Barasa; Mathew Piero Ngugi
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-30       Impact factor: 2.629

Review 7.  Diosgenin and Its Analogs: Potential Protective Agents Against Atherosclerosis.

Authors:  Dan Wang; Xiaolong Wang
Journal:  Drug Des Devel Ther       Date:  2022-07-17       Impact factor: 4.319

8.  The effects of Sutaehwan-Gami on menopausal symptoms induced by ovariectomy in rats.

Authors:  Dong-Il Kim; Min Sun Choi; Sok Cheon Pak; Seung-Bok Lee; Songhee Jeon
Journal:  BMC Complement Altern Med       Date:  2012-11-23       Impact factor: 3.659

9.  Yi qi qing re gao attenuates podocyte injury and inhibits vascular endothelial growth factor overexpression in puromycin aminonucleoside rat model.

Authors:  Yongli Zhan; Liping Yang; Yumin Wen; Huijie Liu; Haojun Zhang; Bin Zhu; Wenbing Han; Yanting Gu; Xueyan Sun; Xi Dong; Tingting Zhao; Huixia Ma; Ping Li
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-21       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.